United Fire Group, Inc. Reports on Annual Meeting of Shareholders Director Elections to the Board of Directors Announced Director Elections to the Board of Directors CEDAR RAPIDS, Iowa, May 16, 2024 (GLOBE NEWSWIRE) -- United Fire Group, Inc. (Nasdaq: UFCS) (the "Company" or "UFG") announced today that its shareholders elected four Class C Directors to our 11-member board of directors at the 2024 Annual Meeting of Shareholders held on May 15, 2024. The following individuals were each elected as Class C Directors to serve three-year terms expiring in 2027. Mark A. Green, Operating Part...
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results Combination and monotherapy solid tumor dose escalation data for CLN-619 to be presented in a poster session at ASCO 2024 Annual Meeting CLN-978 development to focus exclusively on autoimmune diseases, starting with systemic lupus erythematosus (SLE) as the first indication Cash and investments of $434.8 million as of March 31, 2024, plus gross proceeds of $280 million from April private placement extends cash runway into 2028 Company appoints David Meek to its Board of Directors CAMBRIDGE, ...
United Fire Group, Inc. Declares a Common Stock Quarterly Cash Dividend of $0.16 per Share CEDAR RAPIDS, IOWA , May 15, 2024 (GLOBE NEWSWIRE) -- Today, the Board of Directors of United Fire Group, Inc. (Nasdaq: UFCS) ("UFG") declared a common stock quarterly cash dividend of $0.16 per share. This dividend will be payable June 14, 2024 to shareholders of record as of May 31, 2024. UFG has a long history of paying quarterly dividends, with the quarterly cash dividend declared today marking the 225th consecutive quarterly dividend paid, dating back to March 1968. About UFG Founded i...
Moody's Ratings (Moody's) today assigned a Ba3 rating to PRA Group, INC.'s (PRA) $400 million 2030 backed senior unsecured notes. RATINGS RATIONALE The announced notes will rank pari passu with PRA's existing senior unsecured notes, currently rated Ba3. The new issuance will replace PRA's outsta...
Sysco Celebrates Growth of Electric Fleet to Nearly 120 EVs Across Four Countries Featured delivery of 10 electric heavy-duty tractors at an event in Sysco’s hometown city, Houston, TX HOUSTON, May 14, 2024 (GLOBE NEWSWIRE) -- Today, Sysco Corporation (NYSE:SYY), the world’s largest food distributor, celebrated the arrival of 10 heavy-duty electric tractors to the fleet at its Houston, Texas operating site, reaching a total of nearly 120 electric vehicles (EVs) globally. This addition is a major step toward Sysco’s goal to reduce its direct emissions by 27.5% by 2030. In total, Sysco...
Atea Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update Full Enrollment Achieved in Global Phase 3 SUNRISE-3 Trial for Treatment of COVID-19 with Results Expected 2H’24 Global Phase 2 HCV Study On Track to Report Complete SVR12 Results 2H’24 Multiple Presentations Showcasing Preclinical and New Phase 2 Efficacy Data to be Presented at European Association for the Study of the Liver (EASL) Congress 2024 Conference Call at 4:30 pm ET Today BOSTON, May 14, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinic...
Sysco Celebrates Arrival of Heavy-Duty Electric Vehicles in Its Headquarters City of Houston, TX, Growth of Electric Fleet Globally HOUSTON, May 14, 2024 (GLOBE NEWSWIRE) -- Sysco is hosting a news conference to celebrate the arrival of new heavy duty electric vehicles to the company’s hometown Houston distribution facility, the first for Sysco in Texas. The company will also announce its progress in deploying EVs across the United States and globally. Sysco’s Chief Administrative Officer, Neil Russell, will provide formal remarks and members of the media will have the opportunity to ask...
Two Directors at M&T Bank Corp sold/sold after exercising options 24,559 shares at between 152.390USD and 153.781USD. The significance rating of the trade was 79/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the...
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones - Investigational New Drug application for non-small cell lung cancer trial with luvelta cleared by U.S. Food and Drug Administration; Phase 2 on track to begin dosing in the second half of 2024 - - Patient expansion phase well underway in Phase 2 study of luvelta in combination with bevacizumab; enrollment is expected to complete in the first half of 2024 - - The randomized portion of REFRαME-O1, the registration-enabling study of luvelta for patients with p...
Royalty Pharma to Present at Upcoming Investor Conferences NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of May: RBC Capital Markets 2024 Global Healthcare Conference on Tuesday, May 14 at 9:00 a.m. ETBofA Securities 2024 Healthcare Conference on Wednesday, May 15 at 6:00 p.m. ET / 3:00 p.m. PT The webcasts will be accessible from Royalty Pharma’s “Events” page at . Webcasts will also be archived for a minimum of thirty days. About Royalty Pharma Fou...
Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting In vitro data showcases CNTY-101’s ability to induce CD19-specific cytolysis of B-cells and potential to treat B-cell driven autoimmune diseases including systemic lupus erythematosus (SLE)Preclinical data demonstrates potential utility of using a synthetic ligand targeting CD300a as a universal strategy for preventing NK mediated rejection in allogeneic cell therapies PHILADELPHIA, May 10, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: IPSC), an innovative biote...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.